Differential persistence of neutralizing antibody against SARS-CoV-2 in post immunized Bangladeshi population

被引:3
作者
Roy, Dipa [1 ]
Rahman, Md Mosfequr [2 ]
Chaity, Arnaba Saha [1 ]
Abu Reza, Md [3 ]
Haque, Ariful [1 ]
机构
[1] Univ Rajshahi, Inst Biol Sci, Mol Pathol Lab, Rajshahi 6205, Bangladesh
[2] Univ Rajshahi, Dept Populat Sci & Human Resource Dev, Rajshahi 6205, Bangladesh
[3] Univ Rajshahi, Dept Genet Engn & Biotechnol, Mol Biol & Prot Sci Lab, Rajshahi 6205, Bangladesh
关键词
CORONAVIRUS; INFECTION; SPIKE;
D O I
10.1038/s41598-022-18302-9
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Development of effective vaccines have been immensely welcomed by the world to prevent the transmission of SARS-CoV-2. However, the duration and clinical implications of antibody-mediated natural immunity in SARS-CoV-2 have not been adequately elucidated alongside some other immune system transforming factors. In a cohort study, we measured NAb titer following the 2nd immunization dosage of the CoviShield (AZD1222) vaccine. The enzyme-linked immunoassay was used to look for SARS-CoV-2-specific NAb. We measured NAb at 30 days after the 2nd dosage of immunization and > 96% titer was detected in 42.9% of subjects, but only 5.1% of subjects retained the same level after 180 days. The median NAb titer dropped significantly, from 92% at 30 days to 58% at 180 days (p < 0.001). Besides, there were significant differences observed in NAb titer after 180 days by age, sex, COVID-19 infection, tobacco use, and asthma patients. However, SARS-CoV-2 infection along with two dosages of immunization upheld NAb titer (p < 0.001) even at the end of the study period.
引用
收藏
页数:11
相关论文
共 50 条
[21]   A community study of neutralizing antibodies against SARS-CoV-2 in China [J].
Lv, Yitong ;
Huang, Lei ;
Wang, Junhu ;
He, Hui ;
Song, Libo ;
He, Jia ;
Xu, Lida ;
Yu, Changyuan ;
Mei, Ying ;
Gao, Qi .
FRONTIERS IN IMMUNOLOGY, 2023, 14
[22]   Potently neutralizing and protective human antibodies against SARS-CoV-2 [J].
Zost, Seth J. ;
Gilchuk, Pavlo ;
Case, James Brett ;
Binshtein, Elad ;
Chen, Rita E. ;
Nkolola, Joseph P. ;
Schafer, Alexandra ;
Reidy, Joseph X. ;
Trivette, Andrew ;
Nargi, Rachel S. ;
Sutton, Rachel E. ;
Suryadevara, Naveenchandra ;
Martinez, David R. ;
Williamson, Lauren E. ;
Chen, Elaine C. ;
Jones, Taylor ;
Day, Samuel ;
Myers, Luke ;
Hassan, Ahmed O. ;
Kafai, Natasha M. ;
Winkler, Emma S. ;
Fox, Julie M. ;
Shrihari, Swathi ;
Mueller, Benjamin K. ;
Meiler, Jens ;
Chandrashekar, Abishek ;
Mercado, Noe B. ;
Steinhardt, James J. ;
Ren, Kuishu ;
Loo, Yueh-Ming ;
Kallewaard, Nicole L. ;
McCune, Broc T. ;
Keeler, Shamus P. ;
Holtzman, Michael J. ;
Barouch, Dan H. ;
Gralinski, Lisa E. ;
Baric, Ralph S. ;
Thackray, Larissa B. ;
Diamond, Michael S. ;
Carnahan, Robert H. ;
Crowe, James E., Jr. .
NATURE, 2020, 584 (7821) :443-+
[23]   The development of neutralizing antibodies against SARS-CoV-2 and their common features [J].
Liu, Liu Daisy ;
Lian, Chaoyang ;
Yeap, Leng-Siew ;
Meng, Fei-Long .
JOURNAL OF MOLECULAR CELL BIOLOGY, 2020, 12 (12) :980-986
[24]   A broad neutralizing nanobody against SARS-CoV-2 engineered from an approved drug [J].
Liu, Qianyun ;
Lu, Yuchi ;
Cai, Chenguang ;
Huang, Yanyan ;
Zhou, Li ;
Guan, Yanbin ;
Fu, Shiying ;
Lin, Youyou ;
Yan, Huan ;
Zhang, Zhen ;
Li, Xiang ;
Yang, Xiuna ;
Yang, Haitao ;
Guo, Hangtian ;
Lan, Ke ;
Chen, Yu ;
Hou, Shin-Chen ;
Xiong, Yi .
CELL DEATH & DISEASE, 2024, 15 (06)
[25]   Structural Characterization of a Neutralizing Nanobody With Broad Activity Against SARS-CoV-2 Variants [J].
Li, Tingting ;
Zhou, Bingjie ;
Luo, Zhipu ;
Lai, Yanling ;
Huang, Suqiong ;
Zhou, Yuanze ;
Li, Yaning ;
Gautam, Anupriya ;
Bourgeau, Salome ;
Wang, Shurui ;
Bao, Juan ;
Tan, Jingquan ;
Lavillette, Dimitri ;
Li, Dianfan .
FRONTIERS IN MICROBIOLOGY, 2022, 13
[26]   Long-term persistence of SARS-CoV-2 neutralizing antibody responses after infection and estimates of the duration of protection [J].
Lau, Eric H. Y. ;
Hui, David S. C. ;
Tsang, Owen T. Y. ;
Chan, Wai-Hung ;
Kwan, Mike Y. W. ;
Chiu, Susan S. ;
Cheng, Samuel M. S. ;
Ko, Ronald Lw ;
Li, John K. C. ;
Chaothai, Sara ;
Tsang, Chi H. ;
Poon, Leo L. M. ;
Peiris, Malik .
ECLINICALMEDICINE, 2021, 41
[27]   Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants [J].
Qu, Yuanyuan ;
Zhang, Xueyan ;
Wang, Meiyu ;
Sun, Lina ;
Jiang, Yongzhong ;
Li, Cheng ;
Wu, Wei ;
Chen, Zhen ;
Yin, Qiangling ;
Jiang, Xiaolin ;
Liu, Yang ;
Li, Chuan ;
Li, Jiandong ;
Ying, Tianlei ;
Li, Dexin ;
Zhan, Faxian ;
Wang, Youchun ;
Guan, Wuxiang ;
Wang, Shiwen ;
Liang, Mifang .
VIROLOGICA SINICA, 2021, 36 (05) :934-947
[28]   SARS-CoV-2 structural features may explain limited neutralizing-antibody responses [J].
Bachmann, Martin F. ;
Mohsen, Mona O. ;
Zha, Lisha ;
Vogel, Monique ;
Speiser, Daniel E. .
NPJ VACCINES, 2021, 6 (01)
[29]   Neutralizing and binding antibody responses to SARS-CoV-2 with hybrid immunity in pregnancy [J].
Li, Lin ;
Matsui, Yusuke ;
Prahl, Mary K. ;
Cassidy, Arianna G. ;
Golan, Yarden ;
Jigmeddagva, Unurzul ;
Ozarslan, Nida ;
Lin, Christine Y. ;
Buarpung, Sirirak ;
Gonzalez, Veronica J. ;
Chidboy, Megan A. ;
Basilio, Emilia ;
Lynch, Kara L. ;
Song, Dongli ;
Jegatheesan, Priya ;
Rai, Daljeet S. ;
Govindaswami, Balaji ;
Needens, Jordan ;
Rincon, Monica ;
Myatt, Leslie ;
Taha, Taha Y. ;
Montano, Mauricio ;
Ott, Melanie ;
Greene, Warner C. ;
Gaw, Stephanie L. .
NPJ VACCINES, 2024, 9 (01)
[30]   Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans [J].
Vanshylla, Kanika ;
Di Cristanziano, Veronica ;
Kleipass, Franziska ;
Dewald, Felix ;
Schommers, Philipp ;
Gieselmann, Lutz ;
Gruell, Henning ;
Schlotz, Maike ;
Ercanoglu, Meryem S. ;
Stumpf, Ricarda ;
Mayer, Petra ;
Zehner, Matthias ;
Heger, Eva ;
Johannis, Wibke ;
Horn, Carola ;
Suarez, Isabelle ;
Jung, Norma ;
Salomon, Susanne ;
Eberhardt, Kirsten Alexandra ;
Gathof, Birgit ;
Faetkenheuer, Gerd ;
Pfeifer, Nico ;
Eggeling, Ralf ;
Augustin, Max ;
Lehmann, Clara ;
Klein, Florian .
CELL HOST & MICROBE, 2021, 29 (06) :917-+